Evidence map›Paper›PMID 30560521›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2020

Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An

Andrei Todica, Johannes Siebermair, Julia Schiller, Mathias J Zacherl, Wolfgang P Fendler, Steffen Massberg, Peter Bartenstein, Clemens C Cyran, Stefan Kääb, Marcus Hacker and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Diagnostic Efficacy ofDiagnostics (Basel, Switzerland) · 2024
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Andrei TodicaDepartment of Nuclear Medicine, University of Munich, Munich, Germany.
Johannes SiebermairDepartment of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.
Julia SchillerDepartment of Nuclear Medicine, University of Munich, Munich, Germany.
Mathias J ZacherlDepartment of Nuclear Medicine, University of Munich, Munich, Germany.
Wolfgang P FendlerDepartment of Nuclear Medicine, University of Munich, Munich, Germany.
Steffen MassbergDepartment of Cardiology, University of Munich, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University of Munich, Munich, Germany.
Clemens C CyranDepartment of Clinical Radiology, University of Munich, Munich, Germany.
Stefan KääbDepartment of Cardiology, University of Munich, Munich, Germany.
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. marcus.hacker@meduniwien.ac.at.
Reza WakiliDepartment of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.
Sebastian LehnerDepartment of Nuclear Medicine, University of Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DEWest German Heart and Vascular Center Essen · DEMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of the study was to evaluate a novel approach for the quantification of right ventricular sympathetic dysfunction in patients diagnosed with ARVC/D through state-of-the-art functional SPECT/CT hybrid imaging.

methodsSympathetic innervation of the heart was assessed using

resultsThere was a significant difference in the LV/M ratio between the ARVC/D and the IVF groups (3.2 ± 0.5 vs. 3.9 ± 0.8, P = 0.014), with a cut-off value of 3.41 (77% sensitivity, 80% specificity, AUC 0.78). There was a highly significant difference in the mean RV/M ratios between both groups (1.6 ± 0.3 vs. 2.0 ± 0.2, P = 0.001), with optimal cut-off for discrimination at 1.86 (88% sensitivity, 90% specificity, AUC 0.93).

conclusionEmploying state-of-the-art functional SPECT/CT hybrid imaging, we could reliably assess and quantify right and left ventricular sympathetic innervation. The RV/M ratio was significantly lower in patients diagnosed with ARVC/D and provided sensitive and specific discrimination between patients with ARVC/D and IVF patients.

Indexed as

3-IodobenzylguanidineVentricular Function, RightArea Under CurveArrhythmogenic Right Ventricular DysplasiaCardiomyopathiesFemaleHeart VentriclesHumansMaleMediastinumMiddle AgedMultimodal ImagingProspective StudiesROC CurveSensitivity and SpecificitySympathetic Nervous System3-IodobenzylguanidineARVCIVFMIBGQuantificationSPECTSympathetic innervation

Identifiers

PMID30560521
PMCPMC7749057
OpenAlexW2905250463

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.